JP Morgan Maintains Overweight on Boston Scientific, Raises Price Target to $72
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Robbie Marcus has maintained an Overweight rating on Boston Scientific (NYSE:BSX) and increased the price target from $60 to $72.
February 01, 2024 | 2:24 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
JP Morgan analyst Robbie Marcus reaffirmed an Overweight rating on Boston Scientific and raised the price target from $60 to $72.
The increase in price target by a reputable analyst like Robbie Marcus from JP Morgan is a strong positive signal for Boston Scientific. It suggests a bullish outlook on the company's future performance and potential for stock price appreciation. This kind of endorsement typically leads to increased investor confidence and can drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100